Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,052 | -56,948 | -43,756 | -29,298 | -13,027 |
| Depreciation Amortization | 278 | 1,242 | 876 | 582 | 256 |
| Accounts receivable | -22 | 24,396 | 18,593 | 14,266 | 4,165 |
| Other Working Capital | -7,480 | 14,683 | 7,815 | 5,850 | -4,365 |
| Other Operating Activity | 1,028 | -15,624 | -11,795 | -9,198 | -1,356 |
| Operating Cash Flow | $-12,248 | $-32,251 | $-28,267 | $-17,798 | $-14,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11,939 | 11,373 | 14,064 | -1,487 | 7,789 |
| PPE Investments | -69 | -55 | -54 | -53 | -30 |
| Other Investing Activity | -330 | 0 | 0 | -791 | 0 |
| Investing Cash Flow | $11,540 | $11,318 | $14,010 | $-2,331 | $7,759 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 25,691 | 25,691 | 25,691 | 25,939 |
| Common Stock Issued | 12,335 | 1,605 | 446 | 335 | 310 |
| Common Stock Repurchased | N/A | -61 | -61 | -61 | -61 |
| Other Financing Activity | -410 | -3,480 | -3,000 | -2,450 | -1,900 |
| Financing Cash Flow | $11,925 | $23,755 | $23,076 | $23,515 | $24,288 |
| Beginning Cash Position | 16,444 | 13,622 | 13,622 | 13,622 | 13,622 |
| End Cash Position | 27,661 | 16,444 | 22,441 | 17,008 | 31,342 |
| Net Cash Flow | $11,217 | $2,822 | $8,819 | $3,386 | $17,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,248 | -32,251 | -28,267 | -17,798 | -14,327 |
| Capital Expenditure | -69 | -55 | -54 | -53 | -30 |
| Free Cash Flow | -12,317 | -32,306 | -28,321 | -17,851 | -14,357 |